Rottenstein Law Group Helping To Publicize FDA Conference on Unique Medical Device Identifiers

Share Article

The Rottenstein Law Group, which represents clients with claims stemming from injuries allegedly caused by vaginal mesh products, has learned that the FDA will host a gathering of medical device and healthcare industry stakeholders for a discussion of the agency's unique device identifier program for tracking and monitoring medical technology.

The FDA will be hosting the UDI Conference on Sept. 18 and 19, 2012, in Orlando, Fla., according to the conference’s web site http://www.udiconference.com. Led by the FDA and “pioneers in the medical device industry,” the conference is intended for medical device manufacturers, health care distributors, group purchasing organizations, hospitals, and health care providers who want to better understand how to comply with the FDA’s proposed regulation establishing a single medical device identification system (a UDI system) that is “consistent, unambiguous, standardized, and globally harmonized,” according to the conference’s web site. The unique code assigned to each medical device pursuant to the FDA’s UDI system will be the "key to certain basic identifying information about a device, such as the name of the manufacturer and the type of device, and may represent certain other information… such as its expiration date and batch or lot number," according to a July 3, 2012, FDA press release.

The FDA expects the UDI system to, among other things, "allow more accurate reporting, reviewing and analyzing of adverse event reports so that problem devices can be identified and corrected more quickly" and "provide a standardized identifier that will allow manufacturers, distributors and healthcare facilities to more effectively manage medical device recalls," the agency’s July 3, 2012, press release states.

Rochelle Rottenstein is the devoted advocate of claimants allegedly injured by recalled medical devices—including Boston Scientific's Protegen Sling vaginal mesh product, which was recalled in 1999, according to a May 4, 2009, New York Times article. This experience has made Rottenstein aware of the importance of keeping track of adverse event reports filed in connection with injuries sustained from medical devices. Accordingly, Rottenstein has long been a proponent of the FDA's adoption of a UDI system, which she believes can go a long way toward minimizing the injuries caused by potentially dangerous medical devices.

More information about vaginal mesh lawsuits is available at http://www.vaginalmeshlawsuit.com. The site has vital information about the dangers of these medical devices, along with easy-to-use social media features that allow for easy sharing on sites like Facebook and Twitter. Visitors are also encouraged to link to their own web sites and blogs in order to spread the word about defective medical products and dangerous drugs. Attorney advertising.

About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action lawsuits. For more information, please visit the firm’s web site, or call (888) 9-ROT-LAW.

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
Suite 511
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rochelle Rottenstein, Esq.
Visit website